WARRANTS - Summary of continuity schedule (Details) - $ / shares |
6 Months Ended | 12 Months Ended |
|---|---|---|
Sep. 30, 2020 |
Mar. 31, 2020 |
|
| WARRANTS | ||
| Number of Warrants, Outstanding and exercisable, Beginning balance | 125,034 | 288,517 |
| Weighted-Average Exercise Price, Outstanding and exercisable, Beginning balance | $ 20.07 | $ 40.27 |
| Number of Warrants, Expired | (2,667) | (163,483) |
| Weighted-Average Exercise Price, Expired | $ (37.50) | $ (38.91) |
| Number of Warrants, Outstanding and exercisable, Ending balance | 122,367 | 125,034 |
| Weighted-Average Exercise Price, Outstanding and exercisable, Ending balance | $ 19.69 | $ 20.07 |
| X | ||||||||||
- Definition Weighted average exercise price of non options exercised during the period. No definition available.
|
| X | ||||||||||
- Definition Weighted average exercise price of non options exercised during the period. No definition available.
|
| X | ||||||||||
- Definition Number of shares under non-option equity instrument agreements for which rights to exercise lapsed. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of equity instruments other than options outstanding, including both vested and non-vested instruments. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|